Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Yifang Pharmaceutical, a subsidiary of China Traditional Chinese Medicine Holdings (China TCM), is a leading Chinese pharmaceutical company specializing in the research, production, and sale of Traditional Chinese Medicine (TCM) formula granules. Founded in 1992, the company was a pioneer in the industrialization of TCM granules and has established itself as a dominant player in the domestic Chinese market. Its business model focuses on modernizing traditional herbal medicine through advanced extraction and concentration technologies to provide standardized, convenient dosages for clinical use. The company operates multiple large-scale manufacturing bases and maintains a robust quality control system that adheres to national and international standards. Yifang Pharmaceutical's products are widely used in hospitals across China and are exported to various international markets, supporting the global integration of traditional medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Efang.